(esmo), a leading global full-service systems integrator, developer, and supplier of innovative and advanced automation ...

The largest ever clinical trial of T cell therapy for solid tumors has ended, heralding a new era for precision T cell therapy.

A comprehensive analysis of the Phase II EBV CTL trial conducted at NCCS that identifies biomarkers will be presented at the ...

Incorporating perioperative durvalumab into treatment with neoadjuvant chemotherapy and radical cystectomy prolongs ...

Most common AE is myelosuppression, GI side effect, and transient hypertension. There were no treatment-related deaths. Results are consistent with the data reported on the first 19 patients in Study ...

We recently presented encouraging efficacy and safety data at ESMO on NUC-7738 plus pembrolizumab in patients with metastatic melanoma who were refractory or resistant to PD-1 inhibitors. We are ...

Q3 2024 Earnings Call Transcript November 9, 2024 Operator: Good day, everyone, and welcome to today’s BioAtla Third Quarter 2024 Earnings Call. [Operator Instructions] It is now my pleasure to turn ...

Patients with dMMR colon cancer in a trial for two neoadjuvant cycles of nivolumab/ipilimumab or nivolumab/relatlimab, had ...

Lenvatinib plus pembrolizumab has improved survival rates for patients with intermediate-stage hepatocellular cancer, ...

The largest ever clinical trial of T cell therapy (a type of cell-based immunotherapy) for solid tumours has been completed. Led by a Singapore clinician-investigator, the global, international, ...

男性健康月又称胡子月，是每年11月举行的一项全球性慈善活动，最初由澳大利亚墨尔本的一家慈善组织发起，号召男性蓄须引发公众对男性健康的广泛关注。前列腺癌作为全球第二常见男性肿瘤，是该活动的重要议题之一。近年来，我国的前列腺癌发病率与死亡率均呈持续增长趋 ...